Health & Fitness
Health and Fitness
Health and Fitness
Fri, February 4, 2011
Corgenix to Host Conference Call to Discuss Second Quarter Results
DENVER--([ BUSINESS WIRE ])--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Monday, February 14, 2011, at 4:00 p.m. EST to discuss the Companya™s financial and operating performance for its quarter ended December 31, 2010, and the status of the Companya™s product development and marketing activities.
Corgenix invites all those interested in hearing managementa™s discussion of the quartera™s results to join the call by dialing:
U.S. attendees: (800) 862-9098
International attendees: +1 785 424 1051
Conference code is: CORGENIX
A question-and-answer session will follow the presentation by Corgenix management.
A replay will be available for 30 days following the call by dialing (800) 283-7928 for U.S. participants and +1 402 220 0866 for international participants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the worlda™s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at [ www.corgenix.com ].
